Steve Bates appointed chief executive of the BioIndustry Association
pharmafile | June 25, 2012 | Appointment | Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | BIA, Genzyme, Steve Bates
The BioIndustry Association (BIA) has appointed Steve Bates as its chief executive.
Bates has worked both in biotech and the various levels of UK government for 15 years. He was senior director, External Affairs and Market Access at Genzyme UK and Ireland, during which time he worked on the establishment of the Office for Life Science and was a member of the BIA’s Communications Advisory committee.
Tim Edwards, BIA chairman, said: “We are delighted that Steve is joining the BIA. I am certain that his experience in the bioscience sector and within government will prove to be invaluable. Steve will work with BIA members to engage government on our policy initiatives, such as the Citizens Innovation Fund, and to ensure that the Coalition government delivers on the Strategy for UK Life Sciences.
“I would also like to express the BIA’s gratitude to Glyn Edwards for his contribution to the BIA as interim chief executive.”
Bates added: “Having worked both in government and biotech I know how to be an effective voice for the sector and look forward to working in partnership with government, academia and the health service to enable bioscience companies in the UK to succeed.”
Related Content

Use of Genzyme’s MS drug Lemtrada restricted under ongoing EMA safety review
The EMA has launched a review into Genzyme’s multiple sclerosis drug Lemtrada (alemtuzumab) after reports …

Alnylam and Sanofi close research phase of 2014’s $700m RNAi rare disease partnership
Alnylam and Sanofi have announced their intention to bring to an end the research and …

What the life sciences industry wants from the next UK government
The stakes are high as the UK general election draws ever closer, and the industry …






